Biliary Cystadenocarcinoma Associated with Atrophy of the Left Hepatic Lobe and Hepatolithiasis Mimicking Intrahepatic Cholangiocarcinoma: A Case Report  by Tseng, Chang-An et al.
Kaohsiung J Med Sci April 2004 • Vol 20 • No 4
C.A. Tseng, Y.S. Pan, C.Y. Chen, et al
198
BILIARY CYSTADENOCARCINOMA ASSOCIATED WITH
ATROPHY OF THE LEFT HEPATIC LOBE AND
HEPATOLITHIASIS MIMICKING INTRAHEPATIC
CHOLANGIOCARCINOMA: A CASE REPORT
Chang-An Tseng, Yong-Sang Pan,1 Chiao-Yun Chen,2 Chiang-Shin Liu,3 Deng-Chyang Wu,1
Wen-Ming Wang,1 and Chang-Ming Jan1
Division of Gastroenterology, Department of Internal Medicine, Buddhist Tzu Chi
General Hospital, Dalin, Chia-Yi, and 1Division of Gastroenterology,
Department of Internal Medicine and Departments of 2Radiology and 3Pathology,
Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.
Biliary cystadenocarcinoma and its benign counterpart, biliary cystadenoma, are rare hepatic cystic tumors
arising from the hepatobiliary epithelium. We report the case of a 68-year-old Taiwanese woman who
presented initially with acute cholangitis. A series of imaging studies including abdominal ultrasound,
computerized tomography, endoscopic retrograde cholangiopancreatography, and percutaneous
transhepatic cholangiography showed bilateral intrahepatic duct (IHD) and common bile duct (CBD) stones
with IHD and CBD dilatation, and an ill-defined tumor within the atrophied left hepatic lobe. The patient
underwent surgical resection of the tumor and choledocholithotomy. The pathologic diagnosis was biliary
cystadenocarcinoma. We review this rare disease entity and discuss its unusual radiologic features
mimicking intrahepatic cholangiocarcinoma.
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Biliary cystadenoma and cystadenocarcinoma are rare cys-
tic tumors. They are most commonly intrahepatic. From
ultrasound and computerized tomography (CT), biliary
cystadenoma and cystadenocarcinoma are described as
multilocular cystic lesions with associated internal septa-
tions and nodularities [1]. It is not usually difficult to distin-
guish biliary cystadenoma or cystadenocarcinoma from
predominantly solid lesions of the liver such as cholangiocar-
cinoma and hepatoma. However, they should be differen-
tiated from other hepatic cystic lesions. We present a case
of biliary cystadenocarcinoma associated with atrophy of
the left hepatic lobe and hepatolithiasis mimicking intra-
hepatic cholangiocarcinoma on imaging studies.
CASE PRESENTATION
A 68-year-old Taiwanese woman was well until 1 month
prior to admission, when she developed intermittent
abdominal discomfort located mainly in the right upper
quadrant. Five days prior to admission, she began to have
intermittent fever and chills. She had undergone low ante-
rior resection for rectal adenocarcinoma (Duke’s B) 11 years
previously and cholecystectomy for gallbladder stones 16
years previously.
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On admission, physical examination revealed a body
temperature of 38.3°C, mild icterus, and enlargement of
the right hepatic lobe. Laboratory findings were as fol-
lows: white blood cell count 18,300/mm3 (normal, 4,000–
11,000/mm3), aspartate aminotransferase/alanine
aminotransferase 99/53 IU/L (normal, < 25 IU/L), total
bilirubin 2.6 mg/dL (normal, 0.2–1.0 mg/dL), alkaline
phosphatase 552 IU/L (normal, 50–180 IU/L), γ-glutamyl
transpeptidase 540 IU/L (normal, < 32 IU/L), α-fetoprotein
4.4 ng/mL (normal, < 20 ng/mL), carcinoembryonic antigen
6.74 ng/mL (normal, 0–6 ng/mL), and carbohydrate antigen
19-9 676 U/mL (normal, 0–37 U/mL). Serologic tests for
hepatitis B and hepatitis C infection were negative. Urine
and stool examinations were normal.
History, physical examination and laboratory studies
suggested the possibility of biliary tract infection. Abdominal
ultrasound revealed a small left hepatic lobe with dilated
intrahepatic ducts (IHD). A mixed echoic mass lesion with
some acoustic shadowing was located within the left hepatic
lobe. The right hepatic lobe was enlarged with dilated IHD
and intrahepatic stones (not shown). The common bile duct
(CBD) was also dilated (Figure 1). Abdominal CT disclosed
a hypoattenuated mass lesion in the atrophied left hepatic
lobe, with internal septa and punctate calcified spots in the
septa or along the wall. The right IHD and CBD were dilated
(Figure 2). Endoscopic retrograde cholangiopancreato-
graphy (ERCP) revealed large filling defects in the dilated
CBD (Figure 3A). Endoscopic sphincterotomy did not
include stone removal because of the large stone size
(> 1.5 cm) and lack of facilities (such as mechanical
lithotripsy). The papilla of Vater was bulging, but there was
no mucus excretion. Three days later, percutaneous
transhepatic cholangiography (PTC) was indicated to
evaluate the biliary tree above the obstruction. It showed
amorphous filling defects in the common hepatic duct and
hilum with non-visualization of the left IHD and gallbladder
(Figure 3B). Some of the CBD stones may have passed out
spontaneously, or migrated proximally, and these sequential
changes may be responsible for the imaging findings of the
PTC.
Fever and right upper quadrant pain rapidly resolved
after broad-spectrum antibiotic treatment. The patient was
referred for surgery with the clinical diagnoses of CBD
stones and left intrahepatic cholangiocarcinoma. A left
Figure 1. Sagittal abdominal ultrasound showing: (A) a mixed echoic mass lesion with acoustic shadowing within the atrophic left hepatic lobe
(arrowheads); (B) the dilated common bile duct (arrows).
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hepatic lobectomy and choledocholithotomy were per-
formed without complication. Grossly, the specimen dis-
closed dilated IHD and CBD containing mucinous mate-
rial. An ill-defined lesion measuring 5 × 3  × 2 cm was noted.
The lesion was a yellow-reddish tumor containing mucin.
Microscopically, it showed cysts of varying sizes, with
mucin pooling. The cysts were lined with biliary tract-type
epithelium composed mostly of multilayered neoplastic
cells with cellular and nuclear atypia, mitotic activity, and
invasion of underlying stroma. The pathologic diagnosis
was a mucinous, intrahepatic biliary cystadenocarcinoma
(Figure 4).
DISCUSSION
Biliary cystadenomas and their malignant counterparts,
biliary cystadenocarcinomas, are rare tumors, accounting
Figure 2. Enhanced computerized tomography shows: (A) an atrophic left hepatic lobe with dilated left intrahepatic ducts (arrows) and a bulging,
poorly enhanced, low-density tumor mass with tiny calcified content (arrowheads); (B) the dilated common bile duct (arrowheads).
Figure 3. (A) Endoscopic retro-
grade cholangiopancreatography
reveals large filling defects in the
dilated common bile duct. Biliary
ducts proximal to the filling defect
are not visible. The pancreatic duct
is normal. (B) Post-endoscopic
sphincterotomy percutaneous trans-
hepatic cholangiography shows
amorphous filling defects in the
common hepatic duct and hilum
with non-visualization of the left
intrahepatic ducts and gallbladder.
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for less than 5% of bile duct origin neoplasms [1]. Biliary
cystadenomas are characterized by dense connective tissue
walls lined with a single layer of mucin-secreting cells but
no evidence of atypia or excessive mitosis. Biliary cystadeno-
carcinomas are characterized by papillary projections with
a multilayered cell lining with foci of dysplasia and moderate
mitotic activity [2]. Biliary cystadenomas tend to occur in
middle-aged women with a mean age of 50 years. Patients
with malignant tumors are more than 10 years older than
those with benign tumors [3]. Of the cystadenomas, 83%
arise from the intrahepatic biliary system and 17% arise
from the extrahepatic biliary system [4].
Typically, ultrasound and CT findings in biliary cyst-
adenomas and cystadenocarcinomas are described as mul-
tilocular (rarely unilocular) cystic lesions with associated
internal septations and nodularities [1]. Some authors sug-
gest that the presence of nodules or coarse calcifications
along the wall or septa favor the diagnosis of cystadenocar-
cinoma [1,3]. However, it is not crucial to distinguish biliary
cystadenomas from cystadenocarcinomas preoperatively.
Complete surgical excision is the preferred treatment for
both tumors because of the premalignant nature of cyst-
adenomas and to prevent metastasis in cystadenocarcino-
mas. On the other hand, biliary cystadenomas or cystadeno-
carcinomas must be differentiated from other cystic lesions
of the liver that include simple cysts complicated by
hemorrhage or infection, liver abscesses, hydatid cysts, and
necrotic metastases. The distinction from predominantly
solid neoplasms of the liver, such as more commonly
encountered cholangiocarcinomas or hepatocellular
carcinomas, is not usually difficult.
Figure 4. (A) Multiple cyst formation (hematoxylin & eosin, × 20). (B) Tumor cells show cellular stratification with nuclear atypia, mitotic activity,
and invasion of the underlying stroma (arrows) (hematoxylin & eosin, × 40; inset, × 200).
The characteristics of cholangiocarcinoma on ultrasound
and CT include occupying lobule-like lesions in the edged
area with low density and a blurred boundary encircled by
dilated biliary ducts. Cholangiocarcinoma is often associated
with atrophy of the affected lobe and hypertrophy of the
unaffected lobe, the so-called atrophy-hypertrophy complex
[5]. Many studies suggest that hepatic lesions associated with
lobar atrophy and dilated IHD are suggestive of cholangio-
carcinoma [6–8]. Lobar atrophy of the liver is a rare condition
that is usually caused by obstruction of the biliary system
or portal vein. Portal vein obstruction may be the predominant
factor [7,9]. Takayasu et al report six cholangiocarcinoma
patients with lobar atrophy and bile duct dilatation [7]. All
patients had portal vein obstruction. In our present case,
the cystic component of the left intrahepatic biliary cystade-
nocarcinoma was not predominant, and the margin of the
tumor was not well defined because of its small size and as-
sociation with lobar atrophy and dilated IHD. Furthermore,
there were bilateral IHD and CBD stones, which are consi-
dered risk factors for cholangiocarcinoma [10]. As mentioned
above, this caused some difficulties in the differential diag-
nosis with cholangiocarcinoma. The mechanism of left lobar
atrophy in our case is not clear. It may have been due to
compression of the left trunk of the portal vein secondary to
hepatolithiasis and subsequent dilatation of the left hepatic
ducts [11]. Wang et al reported that one of five patients with
biliary cystadenoma or cystadenocarcinoma had IHD stones
[12]. Lei et al reported cystadenoma with intracystic stone
formation [13]. However, the causal relationship between
hepatolithiasis and cystadenoma or cystadenocarcinoma is
not clear.
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One rare entity, mucin-hypersecreting bile duct tumor,
should also be differentiated from biliary cystadenoma or
cystadenocarcinoma. In mucin-hypersecreting bile duct
tumors, the orifice of the major papilla always shows ex-
trusion of mucoid material. Dilated intra- and extrahepatic
bile ducts with amorphous filling defects are demonstrated
by ERCP. Resected specimens are characterized by the
presence of an intraductal tumor with a papillary surface
comprising innumerable frond-like infoldings of pro-
liferating columnar epithelial cells surrounding slender
fibrovascular stalks [14,15]. The cystic lesions in mucin-
hypersecreting bile duct tumors are basically those of di-
lated bile ducts. They are not true cysts with a closed cavity,
as seen in biliary cystadenoma or cystadenocarcinoma.
However, it may be difficult to differentiate biliary cyst-
adenomas or cystadenocarcinomas, which are in direct
continuity with the biliary tree, from mucin-hypersecreting
bile duct tumors [16].
In conclusion, we report a rare case of biliary cystadeno-
carcinoma with unusual presentation. To our knowledge,
this is the first report of a case of intrahepatic biliary cyst-
adenocarcinoma associated with atrophy of the left he-
patic lobe and hepatolithiasis mimicking intrahepatic
cholangiocarcinoma.
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